Tag: RXII

Blue Horseshoe Stocks: HEAR Recap & More

Turtle Beach Corp. HEAR

Beginning on the 9th of April, we started tracking HEAR, at a low of 2.76. We swung back around on Tuesday to comment on the excellent moves the stock had made to that point, but we have to revisit once again to update readers on the fantastic new highs attained by HEAR yesterday.

The stock traded in a daily range from 10.80-13.88, an intraday pop of 29% As measured from our observed low on this play barely over a month ago, that high mark represented an upswing of 403%

The stock failed to maintain at least half of its daily advance, so a pullback may be in the cards, but we’ll still allow HEAR to continue to occupy a spot on our watchlist in coming sessions.

AT&T Inc. T – Option Ideas

We’re always looking for a good bottom-play in the midst of a reversal, and thanks in part to a bullish day for the markets yesterday, AT&T fits that bill. Not only did it show a spark off of a bottom yesterday, but there is a considerable gap to fill on the chart as you can plainly see on the included snapshot.

We want to signal some weekly calls for the immediate situation, and some extended term calls in the event of a more sustained recovery. For today, we’re going to track the T Weekly $31-32.50 Calls*, and going forward, we’ll keep the T 06/01 $33 & 33.50 Calls on watch as well.

*NEVER trade weekly options on a Friday unless you are an expert level trader with disposable funds!

Extended Watchlist:
FRTA, FSCT, TTD, EPE, RXII, VYGR

Blue Horseshoe Stocks: ALDX Review & More

Aldeyra Therapeutics, Inc. ALDX

The big standout from yesterday morning’s premarket report turned out to be ALDX, which initially drew our attention with an abnormal volume signal, and the release of positive Phase 2a study data for a Dry Eye Disease treatment.

The stock recorded a continuously bullish pattern throughout the day, trading in an impressive range. From it’s early morning low of 6.60, the stock reached a high of 11.05 just prior to the closing bell. That’s an increase 67% on the day, on more than twenty times the monthly average volume. It also easily took the top gainer spot on the NASDAQ board for the session.

ALDX increasing in value by two-thirds in a single session worked well for us yesterday, but such moves also rare and often unsustainable events. It’s difficult to imagine a scenario where the stock doesn’t undergo a consolidation in the session or sessions to come.

Macy’s, Inc. M – Options Review

We want to swing back around for a recap of the performance in a set of Macy’s calls we made a few weeks ago as a longer-term options idea. Typically, when a stock seems set for an extended rebound, we’ll signal contracts whose expiration doesn’t occur for a longer period of time. In this case we highlighted the

It worked out nicely, with M stock making a steady increase over these last few weeks that facilitated a move in those calls from .60-1.37, which comes out to a respectable gain of 128%

______

Fresh Idea:

We also look for quick strike chances as well, and may have one with Mirati Therapeutics, Inc. MRTX today after the stock soared following the presentation of positive cancer trial data at a conference in Chicago.

We’ll be looking for a dip-and-rip pattern off of this morning’s significant premarket gap-up, and will be tracking the MRTX Weekly $7.50 Calls* and possibly even the $10’s if it appears as if MRTX wants to break that ten dollar barrier.

*Never attempt to trade weekly options on a Friday unless you are A.) An expert trader and B.) Have money you can afford to lose. It’s an extremely risky proposition.

Extended Watchlist:
LPTH, ARRY, MBOT, ATOS, RXII

Blue Horseshoe Stocks: JNUG Recap & Much More

Direxion Daily Jr Gld Mnrs Bull 3X ETF  (JNUG) – Recap

Despite only providing a fleeting opportunity for gains on Tuesday morning after we submitted our options trading idea for the JNUG chain, we followed up with a reminder in yesterday’s report that the idea was still in play, and that we’d need to keep our heads on a swivel looking out for the move we were hoping for.

With the help of a Fed rate hike of a quarter of a percentage point, announced by Chairperson Janet Yellen yesterday, our specified contracts, the JNUG 03/31 $7-8 Calls took a serious turn for the better.

The daily ranges and potential profits were as follows:

$7 Calls – Range: .40-1.40 – Max Gain: 250%
$7.50 Calls – Range: .35-1.00 – Max Gain: 186%
$8 Calls – Range: .20-.87 – Max Gain: 335%

Once again, we’re going to reiterate our interest in these ideas, which could be in line to extend their highs, with JNUG gapping up in early trading this morning.

Aralez Pharmaceuticals, Inc. ARLZ

We placed ARLZ on bottom watch yesterday morning in what turned out to be a fantastic stroke of good timing. We just wanted to update readers this morning on the reversal which did indeed occur during the session. While the intraday gain potential topped out at 25% as the stock ran from the open (and also low of day) at 2.11 to as much as 2.63.

The inverted hammer candle that the stock posted yesterday is often thought to be an indicator of the end of a downward pattern, so we’ll be very interested to continue tracking ARLZ in sessions to come. Chart indicators are still looking very ripe, and we’d be surprised if the show was over after just a 25% rise.

Cannabis Sector Comments

Lastly, we just want to address the cannabis sector, particularly those stocks that are connected to legal recreational marijuana. After some very damaging comments made recently by the Trump Administration wherein it was suggested that the government could crack down on legal weed, yesterday we witnessed something of a reversal from Jeff Sessions.

Sessions appeared to hint at insufficient DOJ funding as a primary reason that perhaps the current regime will not be changing Obama-era guidance on leaving the treatment of recreational weed as a states’ rights issue.

On the heels of this development, we’re going to want to keep closer tabs on the cannabis sector once again, particularly those plays that lost a lot of ground after the first round of comments from Washington.

Some of our go-to favorites in the space have been OWCP, TRTC, SING, SGDH, CBIS, and MJNA, so we’ll be tracking these more closely in the days and weeks ahead, along with the sector as a whole, as stated above.

Fresh Options Idea:

The TSLA chart is looking ripe for a recovery, and the stock is gapping up moderately in premarket trading this morning. We want to signal a range of calls to monitor in the TSLA chain to potentially take advantage of what could be a protracted recovery. We’re going to zero in on the TSLA 04/07 $270-277.50 Calls, and monitor them in the days and weeks ahead.

Extended Watchlist:
NAK, ZSAN, ORCL, TPLM, PLX, RXII, IDRA